Lakewood-Amedex Biotherapeutics Inc. Diluted Shares Outstanding (Weighted Average)
Lakewood-Amedex Biotherapeutics Inc. (LABT) reported Diluted Shares Outstanding (Weighted Average) of 1.42 million shares for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-18.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-09-18
- Lakewood-Amedex Biotherapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.42M shares, a 104.44% increase year-over-year.
- Lakewood-Amedex Biotherapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 7.00M shares, a 0.75% increase year-over-year.
- Lakewood-Amedex Biotherapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 694.45K shares.
- Lakewood-Amedex Biotherapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 6.94M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|
| 2026-06-30 | 1.42M shares S-1 · filed 2026-09-18 | 1.06M shares S-1 · filed 2026-09-18 | |
| 2026-03-31 | 7.00M shares 10-Q · filed 2026-05-22 | ||
| 2025-12-31 | 696.37K shares S-1 · filed 2026-09-18 | ||
| 2025-06-30 | 694.45K shares S-1 · filed 2026-09-18 | 694.45K shares S-1 · filed 2026-09-18 | |
| 2025-03-31 | 6.94M shares 10-Q · filed 2026-05-22 | ||
| 2024-12-31 | 691.01K shares S-1 · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B |